Publicación:
Receptores cannabinoides y vías de modulación del dolor.

dc.contributor.authorCastro Barragán, Joséspa
dc.contributor.authorDaniels García, Maríaspa
dc.contributor.authorMartínez Visbal, Alfonsospa
dc.date.accessioned2016-01-01 00:00:00
dc.date.available2016-01-01 00:00:00
dc.date.issued2015-01-01
dc.format.mimetypeapplication/pdfspa
dc.identifier.doi10.32997/rcb-2016-2935
dc.identifier.eissn2389-7252
dc.identifier.issn2215-7840
dc.identifier.urlhttps://doi.org/10.32997/rcb-2016-2935
dc.language.isospaspa
dc.publisherUniversidad de Cartagenaspa
dc.relation.bitstreamhttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/2935/2470
dc.relation.citationeditionNúm. 1 , Año 2016spa
dc.relation.citationendpage103
dc.relation.citationissue1spa
dc.relation.citationstartpage93
dc.relation.citationvolume7spa
dc.relation.ispartofjournalRevista Ciencias Biomédicasspa
dc.relation.referencesFreund TF, Katona I, Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 2003; 83:1017-66. https://doi.org/10.1152/physrev.00004.2003spa
dc.relation.referencesMatsuda LA, Lolait, SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346(6284):561-4. https://doi.org/10.1038/346561a0spa
dc.relation.referencesMuccioli GG. Endocannabinoid biosynthesis and inactivation, from simple to complex. Drug Discov Today. 2010;15(11-12):474-83. https://doi.org/10.1016/j.drudis.2010.03.007spa
dc.relation.referencesHowlett AC, Johnson MR, Melvin LS, Milne GM. Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model. Mol Pharmacol. 1988;33(3):297-302.spa
dc.relation.referencesMunro S, Thomas K.L, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365(6441):61-65. https://doi.org/10.1038/365061a0spa
dc.relation.referencesDíaz I. Mecanismo de transducción de señal de los cannabinoides. Sociedad Española de investigación sobre cannabinoides (SEIC) 2002.Pp 44-45.spa
dc.relation.referencesAlvarez J, Palmer J. The role of endocannabinoids in pain modulation and the therapeutic potential of inhibiting their enzymatic degradation. Current pharmaceutical biotechnology. 2011;12:1644-59. https://doi.org/10.2174/138920111798357357spa
dc.relation.referencesHowlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG. International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002;54:161-202. https://doi.org/10.1124/pr.54.2.161spa
dc.relation.referencesHohmann, A. G, Herkenham M. Neurosci. Lett. 1998;252:13-16. https://doi.org/10.1016/S0304-3940(98)00534-5spa
dc.relation.referencesRodríguez U, Carrillo E. Cannabinoides: neurobiología y usos médicos. Elementos. 2005;12(60):3.spa
dc.relation.referencesFarmacología de los receptores para cannabinoides; Sociedad Española de Investigación sobre Cannabinoides (SEIC) Departamento de Bioquímica y Biología Molecular Facultad de Medicina Universidad Complutense de Madrid 28040 Madrid.spa
dc.relation.referencesDegenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012;379:55-70. https://doi.org/10.1016/S0140-6736(11)61138-0spa
dc.relation.referencesFine P, Rosenfeld M. The Endocannabinoid System, Cannabinoids, and Pain. Rambam Maimonides Medical Journal. 2013;4:4: e0022. https://doi.org/10.5041/RMMJ.10129spa
dc.relation.references1Ware M, Desroches J. Cannabis medicinal y dolor. Pain: Clinical Updates. 2014;22: 1 -10.spa
dc.relation.referencesVolkow N, Baler R. Adverse Health Effects of Marijuana Use. N Engl J Med 2014;370:2219-27. https://doi.org/10.1056/NEJMra1402309spa
dc.relation.referencesActualización sobre el potencial terapéutico de los cannabinoides; Sociedad Española de Investigación sobre Cannabinoides (SEIC) Departamento de Bioquímica y Biología Molecular Facultad de Medicina Universidad Complutense de Madrid 28040 Madrid.spa
dc.relation.referencesPertwee R. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. Br J Pharmacol. 2008;153(2):199-215. https://doi.org/10.1038/sj.bjp.0707442spa
dc.relation.referencesCasadiego A, Lastra S. Cannabis sintético: aspectos toxicológicos, usos clínicos y droga de diseño. Rev. Fac. Med. 2015;63(3): 501-10. https://doi.org/10.15446/revfacmed.v63n3.47460spa
dc.relation.referencesGonzález S, Sagredo O, Gómez M, Ramos JA. Química y metabolismo de los cannabinoides. En: Sociedad Española de Investigación Sobre Cannabinoides. Guía básica sobre los cannabinoides. Madrid: Universidad Complutense de Madrid; 2009. p. 13-22.spa
dc.relation.referencesPertwee R. The diverse CB1 and CB2 receptor pharmacology of threeplant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. Br J Pharmacol. 2008;153(2):199-215. https://doi.org/10.1038/sj.bjp.0707442spa
dc.relation.referencesFine P, Rosenfeld M. The Endocannabinoid System, Cannabinoids, and Pain. Rambam Maimonides Med J. 2013;4(4): e0022. https://doi.org/10.5041/RMMJ.10129spa
dc.relation.referencesGuzmán M. Galve-Roperh I. Endocannabinoides: un nuevo sistema de comunicación en el cerebro. Farmacia.2010;11:173-79. https://doi.org/10.18567/sebbmdiv_ANC.2010.11.1spa
dc.relation.referencesNetzahualcoyotzi, C. Muñoz, N. Martínez, I. Florán, B. Limón, D. La marihuana y el sistema endocanabinoide: de sus efectos recreativos a la terapéutica. Rev Biomed. 2009;20:128-153.spa
dc.relation.referencesWhitlow, C. Freedland, C. Porrino, L. Functional consequences of the repeated administration of Delta9-tetrahydrocannabinol in the rat. Drug Alcohol Depend. 2003;71:169-77. https://doi.org/10.1016/S0376-8716(03)00135-2spa
dc.relation.referencesMurillo, E. Drucker, R. Endocanabinoides y su modulación en el sueño. Arch Neurocien, México. 2006:11(3): 185-93.spa
dc.relation.referencesSvíženská I, Dubový P, Šulcová A. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures - A short review. Pharmacol Biochem Behav. 2008;90(4):501-11. https://doi.org/10.1016/j.pbb.2008.05.010spa
dc.relation.referencesAbood ME, Martin BR. Molecular neurobiology of the cannabinoid receptor. International Review of Neurobiology. 1996;39:197-221. https://doi.org/10.1016/S0074-7742(08)60667-4spa
dc.relation.referencesSociety for Neuroscience. Cannabinoids and animal physiology. 1998.spa
dc.relation.referencesPalazzo E, Luongo L, Novelli V. The role of cannabinoid receptors in the descending modulation of pain. Pharmaceuticals (Basel). 2010;3(8):2661-73. https://doi.org/10.3390/ph3082661spa
dc.relation.referencesBequet, F., Uzabiaga, F., Desbazeille, M., Ludwiczak, P., Maftouh, M., Picard, C., Scatton, B. & Le Fur, G. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.Eur. J. Neurosci. 2007;26:3458-64. https://doi.org/10.1111/j.1460-9568.2007.05900.xspa
dc.relation.references18. Croci T, Manara L, Aureggi G, Guagnini F, Rinaldi-Carmona M, Maffrand JP, et al. In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum. Br J Pharmacol 1998;125:1393-5. https://doi.org/10.1038/sj.bjp.0702190spa
dc.relation.referencesHasanein P, Parviz M, Keshavarz M, Javanmardi K. CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception. Clin Exp Pharmacol Physiol. 2007;34(5-6):439-49. https://doi.org/10.1111/j.1440-1681.2007.04592.xspa
dc.relation.referencesFlores. A., Maldonado R., Berrendero F. Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far. Journal Neuroscience. 2013;7:256. https://doi.org/10.3389/fnins.2013.00256spa
dc.relation.referencesNeubert MJ, Kincaid W, Heinricher MM. Nociceptive facilitating neurons in the rostral ventromedial medulla. Pain. 2004;110:158-165. https://doi.org/10.1016/j.pain.2004.03.017spa
dc.relation.referencesStarowicz K., Malek N., Przewlocka B. Cannabinoid receptors and pain. Focus Article. 2013;2:15-20. https://doi.org/10.1002/wmts.83spa
dc.relation.referencesShu-Jung Hu S. Cheng Ho Y., Chu Chiou L. No more pain upon Gq-protein-coupled receptor activation: role of endocannabinoids. European Journal of Neuroscience.2014;39: 467-84. https://doi.org/10.1111/ejn.12475spa
dc.relation.referencesRusso E., Hohmann A. Role of cannabinoids in pain management. GW Pharmaceuticals. Ther Clin Risk Manag. 2008;4(1):245-259. https://doi.org/10.2147/TCRM.S1928spa
dc.relation.referencesMangieri RA, Piomelli D. Enhancement of endocannabinoid signaling and the pharmacotherapy of depression. Pharmacol Res. 2007;56(5):360-6. https://doi.org/10.1016/j.phrs.2007.09.003spa
dc.relation.referencesGulyas AI, Cravatt BF, Bracey MH, et al. Segregation of two endocannabinoid- hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci. 2004;20(2):441-58. https://doi.org/10.1111/j.1460-9568.2004.03428.xspa
dc.relation.referencesNeubert MJ, Kincaid W, Heinricher MM. Nociceptive facilitating neurons in the rostral ventromedial medulla. Pain. 2004;110:158-65. https://doi.org/10.1016/j.pain.2004.03.017spa
dc.relation.referencesDurnett J. Cannabinoids Modulate Pain by Multiple Mechanisms of Action. The Journal of Pain. 2000;1(1): 2-14. https://doi.org/10.1016/S1526-5900(00)90082-8spa
dc.relation.referencesWalker M, Huang S, Strangman N. Pain modulation by release of the endogenous cannabinoid anandamide. Rev. Psychology.1999;96(21): 14-25. https://doi.org/10.1073/pnas.96.21.12198spa
dc.relation.referencesRodríguez U, Carrillo E. Cannabinoides: neurobiología y usos médicos. Elementos.2005;60(12):3spa
dc.relation.referencesDe Novellis V, Mariani L, Palazzo E, VitaD, Marabese I, Scafuro M, Rossi F, Maione S. Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat. Neuroscience 2005;134: 269-281. https://doi.org/10.1016/j.neuroscience.2005.03.014spa
dc.relation.referencesRea K, Roche M, Finn D. Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate. British Journal of Pharmacology .2007;152:633-648. https://doi.org/10.1038/sj.bjp.0707440spa
dc.relation.referencesspa
dc.rightsRevista Ciencias Biomédicas - 2016spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.creativecommonsEsta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0spa
dc.sourcehttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/2935spa
dc.subjectEndocannabinoidesspa
dc.subjectTetrahidrocannabinolspa
dc.subjectModulación antigénicaspa
dc.subjectEndocannabinoidseng
dc.subjectTetrahydrocannabinoleng
dc.subjectAntigenic modulationeng
dc.titleReceptores cannabinoides y vías de modulación del dolor.spa
dc.title.translatedCannabinoid receptors and pain modulation pathways.eng
dc.typeArtículo de revistaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.localJournal articleeng
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublication

Archivos

Datos de Contacto

Imagen Escudo Universidad de Cartagena

 

 

 

Línea de Atención

Línea Anticorrupción

Síguenos en: